CanSino: Ad5-nCoV

Vaccine Type: Non Replicating Viral Vector

This vaccine may also be referred to as Convidecia

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 2 Trials

Phase 2: 2 Trials

Phase 3: 2 Trials

Approvals: 3 Approvals

  • China
  • Mexico
  • Pakistan

Registered Trials